United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$219Mraised across 7 rounds since 2011, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Rock VenturesReported by EndptsSEC filing: $70M sold, first sale Aug 2018
From a historical funding recordSEC filing: $37M sold, first sale Oct 2015
From a historical funding record and 1 otherSEC filing: $4.7M sold, first sale Jul 2014
Reported by in.finance.yahoo.comSEC filing: $11M sold, first sale Nov 2012
No investor was named in the report.
Reported by sec.govSEC filing: $405K sold, first sale Mar 2011
No investor was named in the report.
Reported by sec.govSEC filing: $805K sold, first sale May 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise Associates
Correlation Ventures
Novartis Venture Fund
Novo Holdings
Sofinnova InvestmentsHBMRock VenturesClarus/ AdageGalera AngelsNan Fung LifeMissing a round, or an investor who was in one? Tell us.
Galera Therapeutics's investors include New Enterprise Associates, Correlation Ventures, Novartis Venture Fund, Novo Holdings and Sofinnova Investments, and 7 more on record.
Galera Therapeutics has raised $219M across 7 rounds since 2011.
Galera Therapeutics's most recent round was an Undisclosed round of $150M in Sept 2018.
Its most recent round, $150M in Sept 2018, is also its largest on record.
Galera Therapeutics's first round on record, in Dec 2012, was backed by New Enterprise Associates, Correlation Ventures and Novartis Venture Fund.
Galera Therapeutics's latest named round is an Undisclosed round, in Sept 2018.
Galera Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
